[
    {
        "@id": "http://purl.org/np/RAGYO-YzYa850-O5g_44ngm3OCOEdOJhNwIabBysG77H8#provenance",
        "@graph": [
            {
                "@id": "http://purl.org/np/RAGYO-YzYa850-O5g_44ngm3OCOEdOJhNwIabBysG77H8#assertion",
                "http://www.w3.org/ns/prov#wasAttributedTo": [
                    {
                        "@id": "https://orcid.org/0000-0002-1468-3557"
                    }
                ]
            }
        ]
    },
    {
        "@id": "http://purl.org/np/RAGYO-YzYa850-O5g_44ngm3OCOEdOJhNwIabBysG77H8#pubinfo",
        "@graph": [
            {
                "@id": "http://purl.org/np/RAGYO-YzYa850-O5g_44ngm3OCOEdOJhNwIabBysG77H8#sig",
                "http://purl.org/nanopub/x/hasAlgorithm": [
                    {
                        "@value": "RSA"
                    }
                ],
                "http://purl.org/nanopub/x/hasPublicKey": [
                    {
                        "@value": "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB"
                    }
                ],
                "http://purl.org/nanopub/x/hasSignature": [
                    {
                        "@value": "WJSKHDkHvF5pI97AfODVSSuuoGGHmcj2X/YcTrOd6TLd7UWKy9WpFxSyV64oEh/6mYGoGyos22dI16+E5ATJIqxAUlNfc+EtY6HCtf3Nr3/zwojqrF/mrMtaCKRVfQqLemynRYmGvwc93KMezAM/ezGRE5aAV8wLUImYA6MjGVE="
                    }
                ],
                "http://purl.org/nanopub/x/hasSignatureTarget": [
                    {
                        "@id": "http://purl.org/np/RAGYO-YzYa850-O5g_44ngm3OCOEdOJhNwIabBysG77H8"
                    }
                ]
            },
            {
                "@id": "http://purl.org/np/RAGYO-YzYa850-O5g_44ngm3OCOEdOJhNwIabBysG77H8",
                "http://purl.org/dc/terms/created": [
                    {
                        "@value": "2021-06-13T16:37:05.692+02:00",
                        "@type": "http://www.w3.org/2001/XMLSchema#dateTime"
                    }
                ],
                "http://purl.org/dc/terms/creator": [
                    {
                        "@id": "https://orcid.org/0000-0002-1468-3557"
                    }
                ],
                "https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate": [
                    {
                        "@id": "http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM"
                    }
                ],
                "https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate": [
                    {
                        "@id": "http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM"
                    }
                ],
                "https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate": [
                    {
                        "@id": "http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs"
                    }
                ]
            }
        ]
    },
    {
        "@id": "http://purl.org/np/RAGYO-YzYa850-O5g_44ngm3OCOEdOJhNwIabBysG77H8#Head",
        "@graph": [
            {
                "@id": "http://purl.org/np/RAGYO-YzYa850-O5g_44ngm3OCOEdOJhNwIabBysG77H8",
                "http://www.nanopub.org/nschema#hasAssertion": [
                    {
                        "@id": "http://purl.org/np/RAGYO-YzYa850-O5g_44ngm3OCOEdOJhNwIabBysG77H8#assertion"
                    }
                ],
                "http://www.nanopub.org/nschema#hasProvenance": [
                    {
                        "@id": "http://purl.org/np/RAGYO-YzYa850-O5g_44ngm3OCOEdOJhNwIabBysG77H8#provenance"
                    }
                ],
                "http://www.nanopub.org/nschema#hasPublicationInfo": [
                    {
                        "@id": "http://purl.org/np/RAGYO-YzYa850-O5g_44ngm3OCOEdOJhNwIabBysG77H8#pubinfo"
                    }
                ],
                "@type": [
                    "http://www.nanopub.org/nschema#Nanopublication"
                ]
            }
        ]
    },
    {
        "@id": "http://purl.org/np/RAGYO-YzYa850-O5g_44ngm3OCOEdOJhNwIabBysG77H8#assertion",
        "@graph": [
            {
                "@id": "http://purl.obolibrary.org/obo/DOID_13146",
                "https://w3id.org/biolink/vocab/category": [
                    {
                        "@id": "https://w3id.org/biolink/vocab/Disease"
                    }
                ]
            },
            {
                "@id": "http://purl.org/np/RAGYO-YzYa850-O5g_44ngm3OCOEdOJhNwIabBysG77H8#association",
                "http://www.w3.org/1999/02/22-rdf-syntax-ns#object": [
                    {
                        "@id": "http://purl.obolibrary.org/obo/DOID_13146"
                    }
                ],
                "http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate": [
                    {
                        "@id": "https://w3id.org/biolink/vocab/treats"
                    }
                ],
                "http://www.w3.org/1999/02/22-rdf-syntax-ns#subject": [
                    {
                        "@id": "https://identifiers.org/drugbank:DB00520"
                    }
                ],
                "@type": [
                    "http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement"
                ],
                "http://www.w3.org/2000/01/rdf-schema#label": [
                    {
                        "@value": "caspofungin acetate is an echinocandin antifungal indicated in adults and pediatric patients 3 months of age and older for empirical therapy for presumed fungal infections in febrile neutropenic patients 1 treatment of candidemia and the following candida 1 treatment of esophageal candidiasis 1 treatment of invasive aspergillosis in patients who are refractory to or intolerant of other therapies 1 caspofungin acetate for injection is indicated as empirical therapy for presumed fungal infections in febrile neutropenic adult and pediatric patients 3 months of age and older see clinical studies 14 1 14 5 caspofungin acetate for injection is indicated for the treatment of candidemia and the following candida infections intra abdominal abscesses peritonitis and pleural space infections in adult and pediatric patients 3 months of age and older see clinical studies 14 2 14 5 limitations of use candida caspofungin acetate for injection is indicated for the treatment of esophageal candidiasis in adult and pediatric patients 3 months of age and older see clinical studies 14 3 14 5 limitations of use see clinical studies 14 3 caspofungin acetate for injection is indicated for the treatment of invasive aspergillosis in adult and pediatric patients 3 months of age and older who are refractory to or intolerant of other therapies see clinical studies 14 4 14 5 limitations of use"
                    }
                ],
                "https://w3id.org/biolink/vocab/association_type": [
                    {
                        "@id": "https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation"
                    }
                ],
                "https://w3id.org/biolink/vocab/provided_by": [
                    {
                        "@id": "https://w3id.org/um/NeuroDKG"
                    }
                ],
                "https://w3id.org/biolink/vocab/relation": [
                    {
                        "@id": "https://schema.org/TreatmentIndication"
                    }
                ]
            },
            {
                "@id": "https://identifiers.org/drugbank:DB00520",
                "https://w3id.org/biolink/vocab/category": [
                    {
                        "@id": "https://w3id.org/biolink/vocab/Drug"
                    }
                ]
            }
        ]
    }
]